RNA Analysis Market Trend Analysis and Projected Growth

Comments · 61 Views

Market size is expected to develop revenue and exponential market growth at a remarkable CAGR during the forecast period

According to the new market research report "RNA Analysis Market by Product (Reagents, Instruments, Software, Services), Technology (PCR, Sequencing, Microarrays, RNA Interference), Application (Drug Discovery, Clinical Diagnostics), End User (Pharma, Biotech, CROs), Region - Global Forecast to 2028"

The global RNA analysis market in terms of revenue was estimated to be worth $5.3 billion in 2023 and is poised to reach $9.9 billion by 2028, growing at a CAGR of 13.4% from 2023 to 2028.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=240344576

DRIVER: Growing demand for personalized medicine
With the growing prominence of personalized medicine, there is an increased demand for rapid, highly sensitive, and quantitative methods to analyze proteins and related post-translational modifications in clinical specimens. In addition, as gene variants predict a patient’s likely response to a certain medication, researchers are increasingly focusing on identifying and studying various proteins, modifications, genetic variants, and their relevance to different diseases. Advances in omics technologies have made important contributions to the development of personalized medicine by facilitating the detection of protein biomarkers, proteomics-based molecular diagnostics, as well as pharmacoproteomics.

RESTRAINT: High capital investments
Advancements in various instruments have led to higher prices than previous-generation instruments due to their expensive development process. For instance, in 2022, an Illumina HiSeq X Ten sequencing instrument cost USD 1 million. In 2021, the cost of the same instrument was USD 750,000. Companies rely on accessible structural data and trial-and-error methods to determine the compounds that either stimulate or disable targets. All processes need a large number of laboratory hours, thus increasing the per-sample testing cost. Such high prices of instruments and reagents make it difficult for developing countries to venture into the field of transcriptomics. The high costs involved have led to the lower-than-expected adoption of transcriptomic technologies across the globe.

Companies covered

Key players in the RNA analysis market are Thermo Fisher Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US), Illumina, Inc. (US), Eurofins Scientific (Luxembourg)

Recent Developments by RNA Analysis Industry

  • In October 2022, Agilent Technologies and CMP Scientific Corp. entered into a co-marketing agreement to provide an integrated capillary electrophoresis-mass spectrometry (CE-MS) solution for the life science and pharmaceutical industries.
  • In March 2022, Eurofins acquired Beacon Discovery, a drug discovery-based CRO. Beacon supported the fully integrated drug discovery programs from target validation to pre-clinical candidates.
  • In January 2021, Thermo Fisher acquired Phitonex to provide greater flow cytometry and imaging multiplexing capabilities for protein and cell analysis research needs. Phitonex’s product offerings are also an expansion of the company’s existing protein and cell analysis portfolio.

Report Objectives

  • To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To strategically analyze the market structure and profile the key players of the market and comprehensively analyze their core competencies
  • To forecast the size of the market segments with respect to four regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (Latin America and the Middle East Africa)

Explore the Full Report with Charts, Table of Contents, and List of Figures: https://www.marketsandmarkets.com/Market-Reports/trancriptomics-market-240344576.html

About MarketsandMarkets™:

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines — TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies -helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, and facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn, and Facebook.


Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1–888–600–6441

Email: sales@marketsandmarkets.com

Read more